
Richard A. Rosenberger
Examiner (ID: 3824)
| Most Active Art Unit | 2505 |
| Art Unit(s) | 2506, 2505, 2507, 2877 |
| Total Applications | 2040 |
| Issued Applications | 1682 |
| Pending Applications | 69 |
| Abandoned Applications | 288 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6659591
[patent_doc_number] => 20030134423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Compounds for delivering substances into cells'
[patent_app_type] => new
[patent_app_number] => 10/035223
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 6264
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134423.pdf
[firstpage_image] =>[orig_patent_app_number] => 10035223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/035223 | Compounds for delivering substances into cells | Jan 3, 2002 | Abandoned |
Array
(
[id] => 6474816
[patent_doc_number] => 20020151588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Dissociated glucocorticoid receptor antagonists for the treatment of glucocorticoid associated side effects'
[patent_app_type] => new
[patent_app_number] => 10/029720
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7137
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151588.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029720
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029720 | Dissociated glucocorticoid receptor antagonists for the treatment of glucocorticoid associated side effects | Dec 19, 2001 | Abandoned |
Array
(
[id] => 6552719
[patent_doc_number] => 20020111325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'VEGI, an inhibitor of angiogenesis and tumor growth'
[patent_app_type] => new
[patent_app_number] => 10/012452
[patent_app_country] => US
[patent_app_date] => 2001-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 46118
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111325.pdf
[firstpage_image] =>[orig_patent_app_number] => 10012452
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/012452 | VEGI, an inhibitor of angiogenesis and tumor growth | Dec 11, 2001 | Abandoned |
Array
(
[id] => 6869823
[patent_doc_number] => 20030082512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Process to study changes in gene expression in granulocytic cells'
[patent_app_type] => new
[patent_app_number] => 10/004427
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13730
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082512.pdf
[firstpage_image] =>[orig_patent_app_number] => 10004427
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/004427 | Process to study changes in gene expression in granulocytic cells | Dec 5, 2001 | Abandoned |
Array
(
[id] => 5814720
[patent_doc_number] => 20020039744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-04
[patent_title] => 'Method of nucleic acid sequence selection'
[patent_app_type] => new
[patent_app_number] => 10/002158
[patent_app_country] => US
[patent_app_date] => 2001-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6850
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20020039744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10002158
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/002158 | Method of nucleic acid sequence selection | Dec 4, 2001 | Abandoned |
Array
(
[id] => 6381247
[patent_doc_number] => 20020119944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Use of Ulip-and/or Ulip2 in the treatment of myelin disorders'
[patent_app_type] => new
[patent_app_number] => 09/986632
[patent_app_country] => US
[patent_app_date] => 2001-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13586
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119944.pdf
[firstpage_image] =>[orig_patent_app_number] => 09986632
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/986632 | Use of Ulip-and/or Ulip2 in the treatment of myelin disorders | Nov 8, 2001 | Abandoned |
| 09/936029 | Neurodegenerative disorder related gene | Nov 6, 2001 | Abandoned |
Array
(
[id] => 963567
[patent_doc_number] => 06949379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-27
[patent_title] => 'Aptamer-mediated regulation of gene expression'
[patent_app_type] => utility
[patent_app_number] => 10/036091
[patent_app_country] => US
[patent_app_date] => 2001-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12512
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/949/06949379.pdf
[firstpage_image] =>[orig_patent_app_number] => 10036091
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/036091 | Aptamer-mediated regulation of gene expression | Oct 18, 2001 | Issued |
Array
(
[id] => 6674296
[patent_doc_number] => 20030059899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Method for the hydrophobisation of DNA molecules'
[patent_app_type] => new
[patent_app_number] => 09/962602
[patent_app_country] => US
[patent_app_date] => 2001-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1922
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059899.pdf
[firstpage_image] =>[orig_patent_app_number] => 09962602
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/962602 | Method for the hydrophobisation of DNA molecules | Sep 25, 2001 | Abandoned |
Array
(
[id] => 6534403
[patent_doc_number] => 20020137019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases'
[patent_app_type] => new
[patent_app_number] => 09/816669
[patent_app_country] => US
[patent_app_date] => 2001-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17645
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137019.pdf
[firstpage_image] =>[orig_patent_app_number] => 09816669
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/816669 | Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases | Sep 20, 2001 | Abandoned |
Array
(
[id] => 6774633
[patent_doc_number] => 20030017971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Method for increasing levels of export of mRNA from the nucleus to the cytoplasm by providing in the nucleus recombinant mammalian export protein ALY'
[patent_app_type] => new
[patent_app_number] => 09/945248
[patent_app_country] => US
[patent_app_date] => 2001-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6934
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017971.pdf
[firstpage_image] =>[orig_patent_app_number] => 09945248
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/945248 | Method for increasing levels of export of mRNA from the nucleus to the cytoplasm by providing in the nucleus recombinant mammalian export protein ALY | Aug 30, 2001 | Abandoned |
Array
(
[id] => 1115291
[patent_doc_number] => 06800458
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-05
[patent_title] => 'Manganese superoxide dismutase regulatory elements and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/856766
[patent_app_country] => US
[patent_app_date] => 2001-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 29
[patent_no_of_words] => 33714
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/800/06800458.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856766
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856766 | Manganese superoxide dismutase regulatory elements and uses thereof | Aug 27, 2001 | Issued |
Array
(
[id] => 699699
[patent_doc_number] => 07067643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Systems for the detection of target sequences'
[patent_app_type] => utility
[patent_app_number] => 09/941193
[patent_app_country] => US
[patent_app_date] => 2001-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 124
[patent_figures_cnt] => 154
[patent_no_of_words] => 133468
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067643.pdf
[firstpage_image] =>[orig_patent_app_number] => 09941193
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/941193 | Systems for the detection of target sequences | Aug 27, 2001 | Issued |
Array
(
[id] => 1176841
[patent_doc_number] => 06743626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-01
[patent_title] => 'Artificial salivary gland'
[patent_app_type] => B2
[patent_app_number] => 09/938706
[patent_app_country] => US
[patent_app_date] => 2001-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8358
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/743/06743626.pdf
[firstpage_image] =>[orig_patent_app_number] => 09938706
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/938706 | Artificial salivary gland | Aug 22, 2001 | Issued |
Array
(
[id] => 1059421
[patent_doc_number] => 06852511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-08
[patent_title] => 'Heat-inducible promoter'
[patent_app_type] => utility
[patent_app_number] => 09/927811
[patent_app_country] => US
[patent_app_date] => 2001-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 11618
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 332
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852511.pdf
[firstpage_image] =>[orig_patent_app_number] => 09927811
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/927811 | Heat-inducible promoter | Aug 8, 2001 | Issued |
Array
(
[id] => 634027
[patent_doc_number] => 07129083
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-31
[patent_title] => 'PiggyBac transformation system'
[patent_app_type] => utility
[patent_app_number] => 09/915840
[patent_app_country] => US
[patent_app_date] => 2001-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 38
[patent_no_of_words] => 8590
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/129/07129083.pdf
[firstpage_image] =>[orig_patent_app_number] => 09915840
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/915840 | PiggyBac transformation system | Jul 26, 2001 | Issued |
Array
(
[id] => 7466175
[patent_doc_number] => 20040198678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Intravascular delivery of non-viral nucleic acid'
[patent_app_type] => new
[patent_app_number] => 09/877436
[patent_app_country] => US
[patent_app_date] => 2001-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15323
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198678.pdf
[firstpage_image] =>[orig_patent_app_number] => 09877436
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/877436 | Intravascular delivery of non-viral nucleic acid | Jun 6, 2001 | Abandoned |
Array
(
[id] => 1059619
[patent_doc_number] => 06852709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-08
[patent_title] => 'Biologically useful polyphosphates'
[patent_app_type] => utility
[patent_app_number] => 09/871602
[patent_app_country] => US
[patent_app_date] => 2001-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 16888
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852709.pdf
[firstpage_image] =>[orig_patent_app_number] => 09871602
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/871602 | Biologically useful polyphosphates | May 30, 2001 | Issued |
Array
(
[id] => 773292
[patent_doc_number] => 07001768
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-21
[patent_title] => 'Targeted modification of chromatin structure'
[patent_app_type] => utility
[patent_app_number] => 09/844508
[patent_app_country] => US
[patent_app_date] => 2001-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 30041
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001768.pdf
[firstpage_image] =>[orig_patent_app_number] => 09844508
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/844508 | Targeted modification of chromatin structure | Apr 26, 2001 | Issued |
Array
(
[id] => 744193
[patent_doc_number] => 07026119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-11
[patent_title] => 'Methods for generating hypermutable microbes'
[patent_app_type] => utility
[patent_app_number] => 09/780675
[patent_app_country] => US
[patent_app_date] => 2001-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 15876
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/026/07026119.pdf
[firstpage_image] =>[orig_patent_app_number] => 09780675
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/780675 | Methods for generating hypermutable microbes | Feb 11, 2001 | Issued |